| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30 |
| filingDate |
2012-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2014-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2014511728-A |
| titleOfInvention |
System and method for biphasic transdermal iontophoretic delivery of therapeutic agents |
| abstract |
Various embodiments provide methods and systems for biphasic iontophoretic transdermal delivery of therapeutic agents. Such delivery method embodiments include positioning at least one electrode assembly in electrical communication with the patient's skin. The assembly comprises a solution containing a therapeutic agent that passively diffuses into the skin. The drug dose is delivered from the assembly into the skin using a first current having a property, such as polarity and magnitude, that repels the drug and expels it from the assembly during the first time period. During the second period, the drug is retained in the assembly using a second current having properties that attract the drug so that delivery of the drug to the skin is minimized. The drug dose may be delivered on demand with input from the patient. Embodiments can be used to deliver drugs that cause adverse effects by unwanted passive diffusion. [Selection] Figure 5a |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101889357-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020533148-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7170726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111465427-A |
| priorityDate |
2011-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |